Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

Incidence and outcomes of cancer treatment-related cardiomyopathy among referrals for advanced heart failure

Abstract Background Approximately 2–3% of patients undergoing advanced heart failure therapies such as left ventricular assist devices (LVAD) and orthotropic heart transplantation (OHT) have chemotherapy-related cardiomyopathy, according to analyses of large databases such as United Network for Orga...

Full description

Bibliographic Details
Main Authors:	Raquel Araujo-Gutierrez, Sergio H. Ibarra-Cortez, Jerry D. Estep, Arvind Bhimaraj, Ashrith Guha, Imad Hussain, Myung H. Park, Guillermo Torre-Amione, Barry H. Trachtenberg
Format:	Article
Language:	English
Published:	BMC 2018-03-01
Series:	Cardio-Oncology
Subjects:	Chemotherapy-induced cardiomyopathy Anthracyclines Heart failure Heart transplantation Cancer–related cardiomyopathy Heart transplant
Online Access:	http://link.springer.com/article/10.1186/s40959-018-0029-y

Similar Items

Mitochondria and Doxorubicin-Induced Cardiomyopathy: A Complex Interplay
by: Leonardo Schirone, et al.
Published: (2022-06-01)

Hypertrophic Cardiomyopathy After Heart Transplantation
by: Hans Gao, MD, et al.
Published: (2023-05-01)

CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy
by: Anthony J. Kanelidis, MD, et al.
Published: (2020-09-01)

Clinical case of heart transplantation in the conditions of «the recipient-to-donor» transportation
by: B.M. Todurov, et al.
Published: (2021-03-01)

RESYNCHRONIZING THERAPY LONG-TERM RESULTS IN INFANCY TREATED FOR SECONDARY (ARRHYTHMOGENIC) DILATION CARDIOMYOPATHY AFTER SURGICAL INTERVENTION
by: M. L. Kandinsky, et al.
Published: (2019-02-01)

RESYNCHRONIZING THERAPY LONG-TERM RESULTS IN INFANCY TREATED FOR SECONDARY (ARRHYTHMOGENIC) DILATION CARDIOMYOPATHY AFTER SURGICAL INTERVENTION
by: M. L. Kandinsky, et al.
Published: (2019-02-01)

Reassessment of Gene-Elusive Familial Dilated Cardiomyopathy Leading to the Discovery of a Homozygous AARS2 Variant—The Importance of Regular Reassessment of Genetic Findings
by: Priya Bhardwaj, et al.
Published: (2021-07-01)

A Rare Case of Severe Dilated Cardiomyopathy in Early Infancy
by: Meike Schwendt, et al.
Published: (2021-01-01)

Arrhythmogenic right ventricular cardiomyopathy in recipients on heart transplant waiting list
by: M. A. Simonenko, et al.
Published: (2020-08-01)

Hypertrophic obstructive cardiomyopathy in a heart transplant recipient: a case report
by: G. A. Golovina, et al.
Published: (2021-10-01)

A CASE OF HEART TRANSPLANTATION TO A CHILD AGED 10 YEARS WITH DILATED CARDIOMYOPATHY
by: Lashkovskaya T. A., et al.
Published: (2018-12-01)

Heart transplantation and COVID-19 in the early postoperative period in hypertrophic cardiomyopathy: a clinical case
by: M. R. Zaynetdinov, et al.
Published: (2022-07-01)

Heart transplantation outcomes in arrhythmogenic right ventricular cardiomyopathy: a contemporary national analysis
by: Katherine Giuliano, et al.
Published: (2022-04-01)

The re‐occurrence of cardiomyopathy in propionic acidemia after liver transplantation
by: Gerard T. Berry, et al.
Published: (2020-07-01)

Case Report: Dilated Cardiomyopathy in a Newborn, a Potential Association With SARS-COV-2
by: Estela Azeka, et al.
Published: (2021-08-01)

Symptomatic presentation influences outcomes in pediatric restrictive cardiomyopathy
by: Melissa Lorenzo, et al.
Published: (2023-10-01)

Heart failure in children
by: N Jayaprasad
Published: (2016-01-01)

Novel Therapeutics for Anthracycline Induced Cardiotoxicity
by: Jacqueline T. Vuong, et al.
Published: (2022-04-01)

Prevention and management of anthracycline induced cardiotoxicity: A review
by: Ian Osoro, et al.
Published: (2022-12-01)

Combined Heart and Kidney Transplantation: Initial Clinical Experience
by: Fernando Antibas Atik, et al.
Published: (2022-05-01)

Progressive Left Ventricular Remodeling for Predicting Mortality in Children With Dilated Cardiomyopathy: The Pediatric Cardiomyopathy Registry
by: Paul F. Kantor, et al.
Published: (2024-01-01)

The Public Health Burden of Cardiomyopathies: Insights from a Nationwide Inpatient Study
by: Simon Lannou, et al.
Published: (2020-03-01)

Anthracycline induced cardiotoxicity: biomarkers and “Omics” technology in the era of patient specific care
by: Shayan Moazeni, et al.
Published: (2017-05-01)

A rare case of Takotsubo syndrome in a patient 5 months after heart transplantation
by: Osnat Itzhaki Ben Zadok, et al.
Published: (2020-02-01)

A review of transthyretin cardiac amyloidosis
by: Jhawar Nikita, et al.
Published: (2023-03-01)

Genetic characterization of dilated cardiomyopathy patients undergoing heart transplantation in the Chinese population by whole-exome sequencing
by: Hong Lian, et al.
Published: (2023-07-01)

POST-TRANSPLANTATION CARDIOMYOPATHY: ENERGY-PRODUCING PARTICLE OF CARDIOMYOCYTES AT THE TERMS UP TO 25 YEARS OF ORTHOTOPIC HEART TRANSPLANTATION
by: S. L. Dzemeshkevich, et al.
Published: (2015-11-01)

Management of Advanced Heart Failure in Children with Cancer Therapy-Related Cardiac Dysfunction
by: Hari P. Tunuguntla, et al.
Published: (2021-09-01)

Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission
by: Andrea Montisci, et al.
Published: (2021-09-01)

Restrictive cardiomyopathy. Presentation of seven cases
by: Luis Alfonso Fonseca Sánchez, et al.
Published: (2014-07-01)

CARDIAC TRANSPLANTATION IN YOUNG PATIENT WITH DILATED CARDIOMYOPATHY AND SECONDARY ANTIPHOSPHOLIPID SYNDROME
by: E. V. Shlyakhto, et al.
Published: (2013-03-01)

Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
by: Paul J. Scheel, et al.
Published: (2020-02-01)

Genetic Screening of a Large Panel of Genes Associated with Cardiac Disease in a Spanish Heart Transplanted Cohort
by: Elías Cuesta-Llavona, et al.
Published: (2022-05-01)

Left Ventricular Assist Device Implantation and Concomitant Dor Procedure: a Single Center Experience
by: Andreas Schaefer, et al.
Published: (2020-01-01)

Evolução clínica e capacidade funcional de pacientes com cardiomiopatia dilatada após quatro anos do transplante Clinical and functional capacity of patients with dilated cardiomyopathy after four years of transplantation
by: Daniela Gardano Bucharles Mont'Alverne, et al.
Published: (2012-12-01)

Novel Risk Prediction Model to Determine Adverse Heart Failure Outcomes in Arrhythmogenic Right Ventricular Cardiomyopathy
by: Shi Chen, et al.
Published: (2022-07-01)

The Role of Right Ventriculo–Arterial Coupling in Symptoms Presentation of Patients with Hypertrophic Cardiomyopathy
by: Andreas Angelopoulos, et al.
Published: (2023-07-01)

Shared Decision Making in Cardiac Transplantation During the COVID-19 Pandemic
by: Sunit-Preet Chaudhry, MD, et al.
Published: (2020-07-01)

Acute heart failure after Orthotopic liver transplantation: a case series from one center
by: Sonal Sharma, et al.
Published: (2018-07-01)

Autologous transplantation of bone marrow mononuclear stem cells by mini-thoracotomy in dilated cardiomyopathy: technique and early results
by: Renato Abdala Karam Kalil, et al.